| NCT03318991 |
Clinical Outcomes of Laser Prostatectomy |
https://ClinicalTrials.gov/show/NCT03318991 |
Enrolling by invitation |
National Taiwan University |
2018-10-19 |
| NCT03305861 |
Green LEP vs ThuLEP in Management of Marked Enlarged Prostate |
https://ClinicalTrials.gov/show/NCT03305861 |
Recruiting |
Mansoura University |
2019-12-01 |
| NCT03297281 |
Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) |
https://ClinicalTrials.gov/show/NCT03297281 |
Recruiting |
Clinique Pasteur |
2021-11-30 |
| NCT03264482 |
High Power Thulium Vaporization vs Transurethral Resection of the Prostate for Treatment of BPH |
https://ClinicalTrials.gov/show/NCT03264482 |
Active, not recruiting |
Mansoura University |
2018-12-02 |
| NCT03246880 |
Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients |
https://ClinicalTrials.gov/show/NCT03246880 |
Completed |
Chong Kun Dang Pharmaceutical |
2016-04-30 |
| NCT03240939 |
Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil |
https://ClinicalTrials.gov/show/NCT03240939 |
Completed |
Yuyu Pharma, Inc. |
2017-07-07 |
| NCT03239652 |
Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03239652 |
Recruiting |
National Cheng-Kung University Hospital |
2020-06-30 |
| NCT03230721 |
ThuLEP vs. HoLEP vs. Monopolar Enucleation in Management of BPH |
https://ClinicalTrials.gov/show/NCT03230721 |
Completed |
I.M. Sechenov First Moscow State Medical University |
2017-04-22 |
| NCT03194737 |
Prostatic Urethral Lift in Subject With Acute Urinary Retention |
https://ClinicalTrials.gov/show/NCT03194737 |
Active, not recruiting |
NeoTract, Inc. |
2018-12-31 |
| NCT03191734 |
French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue |
https://ClinicalTrials.gov/show/NCT03191734 |
Completed |
PROCEPT BioRobotics |
2018-07-02 |
| NCT03167294 |
AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03167294 |
Completed |
PROCEPT BioRobotics |
2016-06-30 |
| NCT03157726 |
Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate |
https://ClinicalTrials.gov/show/NCT03157726 |
Recruiting |
Zhujiang Hospital |
2020-06-06 |
| NCT03144596 |
The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil |
https://ClinicalTrials.gov/show/NCT03144596 |
Completed |
Kocatepe University |
2016-02-03 |
| NCT03125889 |
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II |
https://ClinicalTrials.gov/show/NCT03125889 |
Completed |
PROCEPT BioRobotics |
2017-04-18 |
| NCT03125863 |
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03125863 |
Completed |
PROCEPT BioRobotics |
2016-09-03 |
| NCT03123250 |
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II |
https://ClinicalTrials.gov/show/NCT03123250 |
Active, not recruiting |
PROCEPT BioRobotics |
2018-03-27 |
| NCT03109925 |
Use of a Novel Radiopaque Embolic Agent in Prostatic Artery Embolisation for Symptomatic Benign Prostatic Enlargement |
https://ClinicalTrials.gov/show/NCT03109925 |
Recruiting |
University Hospital Southampton NHS Foundation Trust |
2019-10-31 |
| NCT03055624 |
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03055624 |
Completed |
University of California, San Diego |
2019-02-18 |
| NCT03052049 |
Prostatic Artery Embolization (PAE) for Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) Using Bead Block Microspheres |
https://ClinicalTrials.gov/show/NCT03052049 |
Active, not recruiting |
Northwestern University |
2020-03-01 |
| NCT02977832 |
Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02977832 |
Completed |
IRCCS Policlinico S. Matteo |
2016-07-31 |
| NCT02972268 |
Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH |
https://ClinicalTrials.gov/show/NCT02972268 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2017-11-02 |
| NCT02962674 |
To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH. |
https://ClinicalTrials.gov/show/NCT02962674 |
Active, not recruiting |
ProstaCare Singapore Pte. Ltd. |
2019-09-30 |
| NCT02961114 |
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy |
https://ClinicalTrials.gov/show/NCT02961114 |
Active, not recruiting |
Healeon Medical Inc |
2022-12-31 |
| NCT02943070 |
Rezum I Pilot Study for BPH |
https://ClinicalTrials.gov/show/NCT02943070 |
Completed |
Boston Scientific Corporation |
2013-02-28 |
| NCT02940392 |
Rezum FIM Optimization |
https://ClinicalTrials.gov/show/NCT02940392 |
Completed |
Boston Scientific Corporation |
2012-12-31 |
| NCT02930889 |
Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02930889 |
Recruiting |
University of Minnesota |
2020-10-31 |
| NCT02869971 |
Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02869971 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2020-12-31 |
| NCT02855892 |
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH |
https://ClinicalTrials.gov/show/NCT02855892 |
Completed |
GemVax & Kael |
2016-10-31 |
| NCT02846467 |
Information Improvement for Surgical Patients Through Portable Video Media |
https://ClinicalTrials.gov/show/NCT02846467 |
Completed |
Hospital Universitario Puerto Real |
2015-10-31 |
| NCT02839122 |
A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT02839122 |
Completed |
Yuyu Pharma, Inc. |
2016-09-30 |
| NCT02822924 |
Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02822924 |
Recruiting |
Chinese University of Hong Kong |
2020-04-30 |
| NCT02786290 |
The Zenflow Spring System Feasibility and Safety Study |
https://ClinicalTrials.gov/show/NCT02786290 |
Active, not recruiting |
Zenflow, Inc. |
2019-12-31 |
| NCT02778243 |
Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level |
https://ClinicalTrials.gov/show/NCT02778243 |
Completed |
Hopital Foch |
2016-11-12 |
| NCT02757963 |
Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years |
https://ClinicalTrials.gov/show/NCT02757963 |
Completed |
GlaxoSmithKline |
2017-02-27 |
| NCT02757768 |
A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02757768 |
Completed |
Astellas Pharma Inc |
2018-08-14 |
| NCT02715401 |
PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02715401 |
Completed |
Hanmi Pharmaceutical Company Limited |
2015-11-30 |
| NCT02715024 |
Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms |
https://ClinicalTrials.gov/show/NCT02715024 |
Completed |
Astellas Pharma Inc |
2011-04-30 |
| NCT02712411 |
Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02712411 |
Completed |
Hanmi Pharmaceutical Company Limited |
2015-08-31 |
| NCT02681471 |
Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia |
https://ClinicalTrials.gov/show/NCT02681471 |
Completed |
Istanbul University |
2015-04-30 |
| NCT02676544 |
Prostate Embolization for Massive Benign Prostatic Hypertrophy (BPH) |
https://ClinicalTrials.gov/show/NCT02676544 |
Recruiting |
Rhode Island Hospital |
2020-12-31 |
| NCT02656173 |
A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) |
https://ClinicalTrials.gov/show/NCT02656173 |
Completed |
Astellas Pharma Inc |
2017-07-21 |
| NCT02645890 |
Study to Compare the Safety and Pharmacokinetics of CKD-397 |
https://ClinicalTrials.gov/show/NCT02645890 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-12-31 |
| NCT02637960 |
Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02637960 |
Completed |
Vantia Ltd |
2017-07-31 |
| NCT02634489 |
EC905 Pharmacokinetic Profile Study |
https://ClinicalTrials.gov/show/NCT02634489 |
Completed |
Astellas Pharma Inc |
2009-07-31 |
| NCT02625545 |
Study of Median Lobe Prostatic UroLift Procedure |
https://ClinicalTrials.gov/show/NCT02625545 |
Completed |
NeoTract, Inc. |
2017-05-30 |
| NCT02615782 |
A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT02615782 |
Completed |
Chong Kun Dang Pharmaceutical |
2016-04-30 |
| NCT02592473 |
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02592473 |
Recruiting |
University of Virginia |
2021-11-30 |
| NCT02524236 |
Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients. |
https://ClinicalTrials.gov/show/NCT02524236 |
Completed |
Beni-Suef University |
2016-11-30 |
| NCT02509104 |
Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT02509104 |
Completed |
GlaxoSmithKline |
2015-10-10 |
| NCT02506465 |
Pivotal Study to Assess the Safety and Effectiveness of the iTind Device |
https://ClinicalTrials.gov/show/NCT02506465 |
Completed |
Medi-Tate Ltd. |
2018-10-31 |
| NCT02505919 |
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) |
https://ClinicalTrials.gov/show/NCT02505919 |
Completed |
PROCEPT BioRobotics |
2017-07-14 |
| NCT02494349 |
The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. |
https://ClinicalTrials.gov/show/NCT02494349 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2015-11-30 |
| NCT02447367 |
Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers |
https://ClinicalTrials.gov/show/NCT02447367 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2015-09-30 |
| NCT02429219 |
Saline With Alcohol in TransUrethral Resection aNd Photoselective Vaporisation of the Prostate |
https://ClinicalTrials.gov/show/NCT02429219 |
Completed |
University of Magdeburg |
2015-02-28 |
| NCT02423759 |
A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy |
https://ClinicalTrials.gov/show/NCT02423759 |
Completed |
Mansoura University |
2017-01-16 |
| NCT02417844 |
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. |
https://ClinicalTrials.gov/show/NCT02417844 |
Completed |
Boehringer Ingelheim |
2015-05-31 |
| NCT02417831 |
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. |
https://ClinicalTrials.gov/show/NCT02417831 |
Completed |
Boehringer Ingelheim |
2015-05-31 |
| NCT02390882 |
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH |
https://ClinicalTrials.gov/show/NCT02390882 |
Completed |
Hanmi Pharmaceutical Company Limited |
2015-05-31 |
| NCT02366975 |
TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST |
https://ClinicalTrials.gov/show/NCT02366975 |
Completed |
University of Florence |
2017-01-31 |
| NCT02346500 |
Ultrasound-Guided Photoselective Vaporization of the Prostate |
https://ClinicalTrials.gov/show/NCT02346500 |
Completed |
Johns Hopkins University |
2016-11-26 |
| NCT02332538 |
HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH |
https://ClinicalTrials.gov/show/NCT02332538 |
Completed |
Mansoura University |
2016-07-31 |
| NCT02326454 |
A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02326454 |
Completed |
Light Sciences Oncology |
2017-03-29 |
| NCT02313233 |
Research on Benefit of Umooze as Add- on Therapy in Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02313233 |
Completed |
Golden Biotechnology Corporation |
2015-05-31 |
| NCT02303769 |
Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS |
https://ClinicalTrials.gov/show/NCT02303769 |
Completed |
GL Pharm Tech Corporation |
2015-05-31 |
| NCT02283684 |
GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT |
https://ClinicalTrials.gov/show/NCT02283684 |
Completed |
Mansoura University |
2015-11-30 |
| NCT02252367 |
Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT02252367 |
Active, not recruiting |
University of Florence |
2019-01-31 |
| NCT02245490 |
Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms |
https://ClinicalTrials.gov/show/NCT02245490 |
Completed |
Boehringer Ingelheim |
2004-04-30 |
| NCT02244294 |
FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02244294 |
Completed |
Boehringer Ingelheim |
2005-06-30 |
| NCT02244255 |
FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02244255 |
Completed |
Boehringer Ingelheim |
2000-06-30 |
| NCT02244242 |
Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02244242 |
Completed |
Boehringer Ingelheim |
1999-08-31 |
| NCT02244229 |
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients |
https://ClinicalTrials.gov/show/NCT02244229 |
Completed |
Boehringer Ingelheim |
2000-11-30 |
| NCT02239484 |
Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin |
https://ClinicalTrials.gov/show/NCT02239484 |
Completed |
Hanmi Pharmaceutical Company Limited |
2014-09-30 |
| NCT02195622 |
Randomized Controlled Trial Comparing Two Different Morcellators for HoLEP Procedures |
https://ClinicalTrials.gov/show/NCT02195622 |
Completed |
Indiana Kidney Stone Institute |
2015-01-31 |
| NCT02184585 |
Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States |
https://ClinicalTrials.gov/show/NCT02184585 |
Completed |
GlaxoSmithKline |
2015-02-23 |
| NCT02180997 |
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin |
https://ClinicalTrials.gov/show/NCT02180997 |
Completed |
Jeil Pharmaceutical Co., Ltd. |
2015-03-31 |
| NCT02180789 |
A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation |
https://ClinicalTrials.gov/show/NCT02180789 |
Completed |
Astellas Pharma Inc |
2015-01-31 |
| NCT03385161 |
Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03385161 |
Completed |
Cairo University |
2015-06-30 |
| NCT02167919 |
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02167919 |
Completed |
University of North Carolina, Chapel Hill |
2017-05-01 |
| NCT02167009 |
Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams |
https://ClinicalTrials.gov/show/NCT02167009 |
Recruiting |
Tampa General Hospital |
2020-05-31 |
| NCT02145208 |
Study to Assess the Efficacy of Medi-Tate iTind Device |
https://ClinicalTrials.gov/show/NCT02145208 |
Active, not recruiting |
Medi-Tate Ltd. |
2017-12-31 |
| NCT02026908 |
Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT02026908 |
Active, not recruiting |
Northwestern University |
2020-06-01 |
| NCT02121613 |
PERmixon® in LUTS Evaluation Study (PERLES) |
https://ClinicalTrials.gov/show/NCT02121613 |
Completed |
Pierre Fabre Medicament |
2016-06-30 |
| NCT02106182 |
Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02106182 |
Completed |
JW Pharmaceutical |
2016-03-02 |
| NCT02074644 |
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02074644 |
Completed |
Hospital St. Louis, Lisbon, Portugal |
2019-03-03 |
| NCT02072499 |
KTP Green Light Prostatectomy Compared With Open Prostatectomy |
https://ClinicalTrials.gov/show/NCT02072499 |
Completed |
University of Helsinki |
2017-06-30 |
| NCT02058368 |
Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02058368 |
Completed |
GlaxoSmithKline |
2017-03-03 |
| NCT01301599 |
Comparison Between Alpha Blocker Monotherapy and 5ARI Monotherapy Following Combination Therapy in Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT01301599 |
Completed |
Samsung Medical Center |
2013-07-31 |
| NCT01294592 |
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement |
https://ClinicalTrials.gov/show/NCT01294592 |
Completed |
GlaxoSmithKline |
2013-10-17 |
| NCT01294150 |
The Safety and Effectiveness of UroLift: LIFT Pivotal Study |
https://ClinicalTrials.gov/show/NCT01294150 |
Completed |
NeoTract, Inc. |
2013-02-28 |
| NCT01275521 |
A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy |
https://ClinicalTrials.gov/show/NCT01275521 |
Completed |
University Hospital, Bordeaux |
2015-04-28 |
| NCT02054013 |
Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT02054013 |
Active, not recruiting |
Cantonal Hospital of St. Gallen |
2017-09-19 |
| NCT02051036 |
Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study |
https://ClinicalTrials.gov/show/NCT02051036 |
Completed |
Korean Medicine Hospital of Pusan National University |
2015-12-31 |
| NCT02041767 |
Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration |
https://ClinicalTrials.gov/show/NCT02041767 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2015-01-31 |
| NCT02038868 |
A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia |
https://ClinicalTrials.gov/show/NCT02038868 |
Completed |
Astellas Pharma Inc |
2014-04-04 |
| NCT02015806 |
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices |
https://ClinicalTrials.gov/show/NCT02015806 |
Completed |
Brigham and Women’s Hospital |
2015-02-28 |
| NCT02011308 |
KTP (Potassium-titanyl-phosphate) Laser Versus TUR-P (Transurethral Resection of Prostate) |
https://ClinicalTrials.gov/show/NCT02011308 |
Completed |
University of Helsinki |
2015-10-31 |
| NCT01966614 |
Randomized, Double-Blind, Vehicle-Controlled, Multicenter Safety and Efficacy Study of Intraprostatic PRX302 for LUTS BPH |
https://ClinicalTrials.gov/show/NCT01966614 |
Completed |
Sophiris Bio Corp |
2015-12-31 |
| NCT01963312 |
Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms. |
https://ClinicalTrials.gov/show/NCT01963312 |
Completed |
Fundacion Miguel Servet |
2018-04-30 |
| NCT01957189 |
This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples |
https://ClinicalTrials.gov/show/NCT01957189 |
Completed |
GlaxoSmithKline |
2014-01-22 |
| NCT01952912 |
Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates |
https://ClinicalTrials.gov/show/NCT01952912 |
Completed |
Fuzhou General Hospital |
2007-06-30 |
| NCT01942551 |
Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride |
https://ClinicalTrials.gov/show/NCT01942551 |
Completed |
Dongkook Pharmaceutical Co., Ltd. |
2013-12-31 |
| NCT01939184 |
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01939184 |
Completed |
Warner Chilcott |
2014-03-31 |
| NCT01937871 |
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) |
https://ClinicalTrials.gov/show/NCT01937871 |
Completed |
Eli Lilly and Company |
2015-12-31 |
| NCT01924988 |
Prostate Embolization for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01924988 |
Completed |
Georgetown University |
2017-04-30 |
| NCT01922375 |
Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01922375 |
Completed |
Dong-A ST Co., Ltd. |
2012-09-30 |
| NCT01912339 |
Safety and Efficacy Study for the Treatment of BPH (Enlarged Prostate) |
https://ClinicalTrials.gov/show/NCT01912339 |
Completed |
Boston Scientific Corporation |
2015-03-31 |
| NCT01892332 |
The Effective Concentration of Lidocaine With Fentanyl in Lumbar Epidural Anesthesia for Transurethral Resection of Prostate(TURP) in Elderly Patients |
https://ClinicalTrials.gov/show/NCT01892332 |
Completed |
Yonsei University |
2014-01-31 |
| NCT01876706 |
UroLift System TOlerability and ReCovery When Administering Local Anesthesia |
https://ClinicalTrials.gov/show/NCT01876706 |
Completed |
NeoTract, Inc. |
2014-10-31 |
| NCT01846793 |
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) |
https://ClinicalTrials.gov/show/NCT01846793 |
Completed |
Nymox Corporation |
2014-10-31 |
| NCT01835860 |
Prostatic Artery Embolization for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01835860 |
Completed |
Saskatchewan Health Authority - Regina Area |
2015-12-31 |
| NCT03350529 |
MRI Guided Transurethral HIFU for Various Prostate Diseases |
https://ClinicalTrials.gov/show/NCT03350529 |
Active, not recruiting |
Turku University Hospital |
2020-12-31 |
| NCT01781117 |
Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01781117 |
Completed |
Samsung Medical Center |
2016-11-30 |
| NCT01777269 |
Prospective Sexual Function Study for BPH Subjects |
https://ClinicalTrials.gov/show/NCT01777269 |
Completed |
GlaxoSmithKline |
2016-04-05 |
| NCT01757769 |
Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01757769 |
Completed |
Recordati Industria Chimica e Farmaceutica S.p.A. |
2013-03-31 |
| NCT01747577 |
Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) |
https://ClinicalTrials.gov/show/NCT01747577 |
Completed |
Astellas Pharma Inc |
2013-10-31 |
| NCT01732991 |
Assessing the Impact of the PVP With Greenlight Laser Using Prostatic MRI and Contrast-enhanced Ultrasound |
https://ClinicalTrials.gov/show/NCT01732991 |
Completed |
University Hospital, Tours |
2015-03-31 |
| NCT01716104 |
Clinical Trial of Safety and Efficacy of Afalaza in Patients With Symptoms of Benign Prostatic Hyperplasia and Risk of Progression |
https://ClinicalTrials.gov/show/NCT01716104 |
Completed |
Materia Medica Holding |
2016-11-30 |
| NCT01678313 |
Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels |
https://ClinicalTrials.gov/show/NCT01678313 |
Completed |
Buddhist Tzu Chi General Hospital |
2013-08-31 |
| NCT01675895 |
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration |
https://ClinicalTrials.gov/show/NCT01675895 |
Completed |
Diskapi Teaching and Research Hospital |
2011-07-31 |
| NCT01665586 |
Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study |
https://ClinicalTrials.gov/show/NCT01665586 |
Completed |
Yonsei University |
2013-09-30 |
| NCT01657851 |
Bioequivalence - Duodart Against Avodart & Omnic |
https://ClinicalTrials.gov/show/NCT01657851 |
Completed |
GlaxoSmithKline |
2012-12-05 |
| NCT01637701 |
Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate |
https://ClinicalTrials.gov/show/NCT01637701 |
Completed |
Fuzhou General Hospital |
2006-12-31 |
| NCT01631149 |
Effect of Deep BLock on Intraoperative Surgical Conditions |
https://ClinicalTrials.gov/show/NCT01631149 |
Completed |
Leiden University Medical Center |
2013-03-31 |
| NCT01627522 |
Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate |
https://ClinicalTrials.gov/show/NCT01627522 |
Completed |
Shiraz University of Medical Sciences |
2013-03-31 |
| NCT01604811 |
Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia) |
https://ClinicalTrials.gov/show/NCT01604811 |
Completed |
Pierre Fabre Medicament |
2013-10-31 |
| NCT01589263 |
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH) |
https://ClinicalTrials.gov/show/NCT01589263 |
Completed |
VA Office of Research and Development |
2019-09-30 |
| NCT01577693 |
Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT01577693 |
Completed |
GlaxoSmithKline |
2011-08-31 |
| NCT01566292 |
Intraprostatic Botulinum Toxin Type “A” Injection in Patients With Benign Prostatic Hyperplasia and Unsatisfactory Response to Medical Therapy |
https://ClinicalTrials.gov/show/NCT01566292 |
Completed |
Catholic University of the Sacred Heart |
2010-09-30 |
| NCT01533038 |
BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01533038 |
Completed |
NeoTract, Inc. |
2015-10-31 |
| NCT01500057 |
Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01500057 |
Completed |
Brooklyn Urology Research Group |
2016-10-10 |
| NCT01495026 |
A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia |
https://ClinicalTrials.gov/show/NCT01495026 |
Completed |
GlaxoSmithKline |
2012-04-03 |
| NCT01494337 |
Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) |
https://ClinicalTrials.gov/show/NCT01494337 |
Completed |
Royal Victoria Hospital, Canada |
2014-03-31 |
| NCT01471678 |
Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. |
https://ClinicalTrials.gov/show/NCT01471678 |
Completed |
GlaxoSmithKline |
2011-09-07 |
| NCT01460342 |
Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT01460342 |
Completed |
Eli Lilly and Company |
2012-10-31 |
| NCT01454349 |
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT01454349 |
Completed |
Sophiris Bio Corp |
2013-03-31 |
| NCT01438775 |
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT01438775 |
Completed |
Nymox Corporation |
2013-01-31 |
| NCT01436877 |
Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia |
https://ClinicalTrials.gov/show/NCT01436877 |
Completed |
Medi-Tate Ltd. |
2016-09-30 |
| NCT01387893 |
A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01387893 |
Completed |
Kaiser Permanente |
2009-03-31 |
| NCT01342562 |
The Effects of Intrathecal Dexmedetomidine on Spinal Anesthesia Using Diluted Low-Dose Bupivacaine for Transurethral Resection of Prostate in Elderly |
https://ClinicalTrials.gov/show/NCT01342562 |
Completed |
Yonsei University |
2011-10-31 |
| NCT01330927 |
Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH) |
https://ClinicalTrials.gov/show/NCT01330927 |
Completed |
Vantia Ltd |
2011-07-31 |
| NCT01330303 |
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin |
https://ClinicalTrials.gov/show/NCT01330303 |
Completed |
GlaxoSmithKline |
2009-12-22 |
| NCT03595735 |
The Zenflow Spring System Safety, Performance and Effectiveness Study |
https://ClinicalTrials.gov/show/NCT03595735 |
Recruiting |
Zenflow, Inc. |
2020-12-30 |
| NCT04391114 |
Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT04391114 |
Recruiting |
Thunder Bay Regional Research Institute |
2021-10-15 |
| NCT04386941 |
Greenlight Vaporization vs Xpeeda Vaporesection |
https://ClinicalTrials.gov/show/NCT04386941 |
Recruiting |
Thunder Bay Regional Research Institute |
2022-07-10 |
| NCT04331301 |
Needlescopic Enucleation Versus Vapoenucleation of BPH |
https://ClinicalTrials.gov/show/NCT04331301 |
Recruiting |
Benha University |
2020-08-01 |
| NCT04308070 |
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III |
https://ClinicalTrials.gov/show/NCT04308070 |
Completed |
PROCEPT BioRobotics |
2018-03-22 |
| NCT04275076 |
HoLEP Vs BPEP for Large Prostatic Adenoma |
https://ClinicalTrials.gov/show/NCT04275076 |
Completed |
Ain Shams University |
2020-02-01 |
| NCT04271020 |
Urodynamic Feasibility Study Utilizing the UroLift® System |
https://ClinicalTrials.gov/show/NCT04271020 |
Completed |
NeoTract, Inc. |
2019-04-22 |
| NCT04263987 |
A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial A Comparison of Traditional and MOSES Laser Enucleation of the Prostate (MOLEP): A Prospective, Randomized, Double-blinded Control Trial |
https://ClinicalTrials.gov/show/NCT04263987 |
Recruiting |
Vanderbilt University Medical Center |
2020-05-31 |
| NCT04212403 |
Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) |
https://ClinicalTrials.gov/show/NCT04212403 |
Completed |
Jessa Hospital |
2019-12-23 |
| NCT04198103 |
Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT04198103 |
Active, not recruiting |
University of Rome Tor Vergata |
2019-11-01 |
| NCT04146103 |
A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH |
https://ClinicalTrials.gov/show/NCT04146103 |
Completed |
Saint-Joseph University |
2019-01-31 |
| NCT04131907 |
A Clinical Study to Evaluate the Safety and Efficacy of the Optilumeâ„¢ BPH Catheter System in Men With Symptomatic BPH |
https://ClinicalTrials.gov/show/NCT04131907 |
Recruiting |
Urotronic Inc. |
2021-06-30 |
| NCT04108871 |
Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men |
https://ClinicalTrials.gov/show/NCT04108871 |
Recruiting |
The University of Hong Kong |
2021-06-01 |
| NCT04107896 |
Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT04107896 |
Completed |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2018-08-31 |
| NCT04103450 |
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT04103450 |
Enrolling by invitation |
Urovant Sciences GmbH |
2021-07-31 |
| NCT04084938 |
Artery Embolization vs Operation of Benign Prostate Hyperplasia |
https://ClinicalTrials.gov/show/NCT04084938 |
Recruiting |
Oslo University Hospital |
2022-12-31 |
| NCT04044573 |
Focal Laser Ablation for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT04044573 |
Recruiting |
University of Rome Tor Vergata |
2023-04-05 |
| NCT03972371 |
The ProVerum First in Man PROVE Study |
https://ClinicalTrials.gov/show/NCT03972371 |
Active, not recruiting |
ProVerum Medical |
2021-11-30 |
| NCT03966950 |
Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia |
https://ClinicalTrials.gov/show/NCT03966950 |
Recruiting |
University of Sao Paulo |
2019-11-26 |
| NCT03936244 |
Bipolar Plasmakinetic TURP Versus Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT03936244 |
Active, not recruiting |
Hospital Universitario de Fuenlabrada |
2017-12-12 |
| NCT03916536 |
Holmium Laser Versus Thulium Laser Versus Bipolar Enucleation of the Prostate. |
https://ClinicalTrials.gov/show/NCT03916536 |
Recruiting |
Mansoura University |
2021-02-01 |
| NCT03912558 |
Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients. |
https://ClinicalTrials.gov/show/NCT03912558 |
Recruiting |
Butterfly Medical Ltd. |
2019-10-31 |
| NCT03902080 |
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT03902080 |
Recruiting |
Urovant Sciences GmbH |
2020-11-30 |
| NCT03887871 |
Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. “Harnal-D” in Healthy Volunteers After Meal |
https://ClinicalTrials.gov/show/NCT03887871 |
Completed |
Chong Kun Dang Pharmaceutical |
2019-03-22 |
| NCT03856242 |
Benign Prostatic Hyperplasia and Ischemic Heart DIsease |
https://ClinicalTrials.gov/show/NCT03856242 |
Completed |
I.M. Sechenov First Moscow State Medical University |
2017-09-01 |
| NCT03846700 |
Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques |
https://ClinicalTrials.gov/show/NCT03846700 |
Recruiting |
University of Bari |
2019-10-01 |
| NCT03831321 |
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy |
https://ClinicalTrials.gov/show/NCT03831321 |
Recruiting |
Istanbul Medeniyet University |
2019-04-22 |
| NCT03829904 |
The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT03829904 |
Completed |
Taipei Veterans General Hospital, Taiwan |
2020-01-02 |
| NCT03669692 |
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. |
https://ClinicalTrials.gov/show/NCT03669692 |
Recruiting |
Complexo Hospitalario Universitario de A Coruña |
2022-12-10 |
| NCT03653117 |
Transperineal Laser Ablation for Treatment of Benign Prostatic Obstruction |
https://ClinicalTrials.gov/show/NCT03653117 |
Recruiting |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2019-07-31 |
| NCT03600766 |
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study |
https://ClinicalTrials.gov/show/NCT03600766 |
Active, not recruiting |
Mansoura University |
2020-01-01 |
| NCT03577236 |
The Zenflow Spring System EU Safety and Performance Study |
https://ClinicalTrials.gov/show/NCT03577236 |
Recruiting |
Zenflow, Inc. |
2021-12-31 |
| NCT01218243 |
An Efficacy Trial of Electroacupuncture at Points of Bilateral BL33 for Mild and Moderate Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01218243 |
Completed |
Guang’anmen Hospital of China Academy of Chinese Medical Sciences |
2012-03-31 |
| NCT03554070 |
Thulium Fiber Laser Enucleation of the Prostate (ThuFLEP): Efficacy and Safety |
https://ClinicalTrials.gov/show/NCT03554070 |
Active, not recruiting |
I.M. Sechenov First Moscow State Medical University |
2020-03-01 |
| NCT03527589 |
Embosphere® PROstate Post Market Study |
https://ClinicalTrials.gov/show/NCT03527589 |
Active, not recruiting |
Merit Medical Systems, Inc. |
2022-09-01 |
| NCT03503721 |
Bipolar Transurethral Enucleation (BipolEP) vs Bipolar Transurethral Resection of the Prostate |
https://ClinicalTrials.gov/show/NCT03503721 |
Recruiting |
Salzburger Landeskliniken |
2021-01-18 |
| NCT03423979 |
Optilumeâ„¢ BPH Prostatic Drug Coated Balloon Dilation Catheter |
https://ClinicalTrials.gov/show/NCT03423979 |
Active, not recruiting |
Urotronic Inc. |
2019-06-04 |
| NCT01260129 |
Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH |
https://ClinicalTrials.gov/show/NCT01260129 |
Completed |
JW Pharmaceutical |
2010-11-30 |
| NCT01259531 |
Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH) |
https://ClinicalTrials.gov/show/NCT01259531 |
Completed |
JW Pharmaceutical |
2011-09-30 |
| NCT01254071 |
A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. |
https://ClinicalTrials.gov/show/NCT01254071 |
Completed |
GlaxoSmithKline |
2010-12-21 |
| NCT01222650 |
A Comparative Study of KSO-0400 in BPH Patients With LUTS |
https://ClinicalTrials.gov/show/NCT01222650 |
Completed |
Kissei Pharmaceutical Co., Ltd. |
NA |
| NCT01183650 |
A Study of Tadalafil in Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01183650 |
Completed |
Eli Lilly and Company |
2011-04-30 |
| NCT01177436 |
Prostate Cancer Antigen 3 (PCA-3) Gene Project |
https://ClinicalTrials.gov/show/NCT01177436 |
Completed |
Assistance Publique Hopitaux De Marseille |
2011-12-31 |
| NCT01152190 |
A Study in Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01152190 |
Completed |
Eli Lilly and Company |
2012-07-31 |
| NCT01139762 |
A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms |
https://ClinicalTrials.gov/show/NCT01139762 |
Completed |
Eli Lilly and Company |
2012-02-29 |
| NCT01107392 |
Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT01107392 |
Completed |
Allergan |
2012-03-16 |
| NCT01050465 |
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use |
https://ClinicalTrials.gov/show/NCT01050465 |
Completed |
University of Missouri-Columbia |
2010-10-31 |
| NCT01043588 |
TRP Versus Photo Selective Vaporization for Obstructive Benign Prostatic Hyperplasia Management |
https://ClinicalTrials.gov/show/NCT01043588 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-12-31 |
| NCT01021332 |
Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01021332 |
Completed |
Astellas Pharma Inc |
2011-12-14 |
| NCT01018511 |
Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01018511 |
Completed |
Astellas Pharma Inc |
2011-03-31 |
| NCT01002664 |
Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01002664 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-06-30 |
| NCT01002417 |
MCS in the Treatment of Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01002417 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-02-28 |
| NCT01002274 |
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT01002274 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-06-30 |
| NCT01002222 |
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c) |
https://ClinicalTrials.gov/show/NCT01002222 |
Completed |
Health Ever Bio-Tech Co., Ltd. |
2014-02-28 |
| NCT00970632 |
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00970632 |
Completed |
Eli Lilly and Company |
2011-01-31 |
| NCT00969072 |
Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00969072 |
Completed |
GlaxoSmithKline |
2005-02-28 |
| NCT00962390 |
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00962390 |
Completed |
Ausio Pharmaceuticals, LLC |
2016-01-31 |
| NCT00947882 |
A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00947882 |
Completed |
Ferring Pharmaceuticals |
2011-03-31 |
| NCT00945490 |
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018 |
https://ClinicalTrials.gov/show/NCT00945490 |
Completed |
Nymox Corporation |
2014-05-31 |
| NCT00941343 |
Benign Prostatic Hyperplasia in Taiwan |
https://ClinicalTrials.gov/show/NCT00941343 |
Completed |
Sanofi |
2008-09-30 |
| NCT00939120 |
Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) |
https://ClinicalTrials.gov/show/NCT00939120 |
Completed |
Siami, Paul F., M.D. |
2014-09-30 |
| NCT00922506 |
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00922506 |
Completed |
Samsung Medical Center |
2014-05-31 |
| NCT00918983 |
Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00918983 |
Completed |
Nymox Corporation |
2013-11-30 |
| NCT00918034 |
Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00918034 |
Completed |
Light Sciences Oncology |
2011-02-28 |
| NCT00908427 |
Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00908427 |
Completed |
Samsung Medical Center |
2006-05-31 |
| NCT00894517 |
A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00894517 |
Completed |
Allergan |
2012-06-30 |
| NCT00890851 |
Procedure Transurethral Needle Ablation (TUNA) and Hospitalization of Short Duration |
https://ClinicalTrials.gov/show/NCT00890851 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-12-31 |
| NCT00889707 |
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00889707 |
Completed |
Sophiris Bio Corp |
2009-12-31 |
| NCT00880672 |
Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate |
https://ClinicalTrials.gov/show/NCT00880672 |
Completed |
Seoul National University Hospital |
2008-12-31 |
| NCT00877669 |
Efficacy Study of HoLEP and TURP on LUTS Secondary to BPH |
https://ClinicalTrials.gov/show/NCT00877669 |
Completed |
Samsung Medical Center |
2016-07-31 |
| NCT00861757 |
Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00861757 |
Completed |
Eli Lilly and Company |
2010-06-30 |
| NCT00861588 |
Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia |
https://ClinicalTrials.gov/show/NCT00861588 |
Completed |
Chinese University of Hong Kong |
2007-09-30 |
| NCT00855582 |
A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia |
https://ClinicalTrials.gov/show/NCT00855582 |
Completed |
Eli Lilly and Company |
2010-07-31 |
| NCT00848081 |
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers |
https://ClinicalTrials.gov/show/NCT00848081 |
Completed |
Eli Lilly and Company |
2009-12-31 |
| NCT02509975 |
Safety and Efficacy of OCL 503 in Prostate Artery Embolization |
https://ClinicalTrials.gov/show/NCT02509975 |
Completed |
IMBiotechnologies Ltd. |
2018-05-31 |
| NCT00836823 |
Evaluation of Symptom-specific Goal Achievement |
https://ClinicalTrials.gov/show/NCT00836823 |
Completed |
Samsung Medical Center |
2008-08-31 |
| NCT00827814 |
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction |
https://ClinicalTrials.gov/show/NCT00827814 |
Completed |
Samsung Medical Center |
2009-04-30 |
| NCT00827242 |
Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily |
https://ClinicalTrials.gov/show/NCT00827242 |
Completed |
Eli Lilly and Company |
2009-11-30 |
| NCT02737241 |
HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH |
https://ClinicalTrials.gov/show/NCT02737241 |
Completed |
Mansoura University |
2017-03-01 |
| NCT00814736 |
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 |
https://ClinicalTrials.gov/show/NCT00814736 |
Completed |
Pfizer |
2008-09-30 |
| NCT03887858 |
Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. “Harnal-D” in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT03887858 |
Completed |
Chong Kun Dang Pharmaceutical |
2019-03-22 |
| NCT02667938 |
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules |
https://ClinicalTrials.gov/show/NCT02667938 |
Completed |
Hanmi Pharmaceutical Company Limited |
2016-01-31 |
| NCT02578953 |
Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects |
https://ClinicalTrials.gov/show/NCT02578953 |
Completed |
GlaxoSmithKline |
2015-12-15 |
| NCT02431754 |
A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS). |
https://ClinicalTrials.gov/show/NCT02431754 |
Completed |
Eli Lilly and Company |
2016-02-29 |
| NCT01829893 |
PK Comparison of GL2701 With Finasteride and Tamsulosin in Combination |
https://ClinicalTrials.gov/show/NCT01829893 |
Completed |
Korea University Anam Hospital |
2012-02-29 |
| NCT03938194 |
Waterjet Prostate Ablation |
https://ClinicalTrials.gov/show/NCT03938194 |
Recruiting |
Chinese University of Hong Kong |
2020-09-30 |
| NCT03758222 |
Safety and Feasibility of the Mercury Expander System |
https://ClinicalTrials.gov/show/NCT03758222 |
Recruiting |
MedeonBio, Inc. |
2020-12-31 |
| NCT00793819 |
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00793819 |
Completed |
Watson Pharmaceuticals |
2009-10-31 |
| NCT00783094 |
Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension |
https://ClinicalTrials.gov/show/NCT00783094 |
Completed |
Eli Lilly and Company |
2009-06-30 |
| NCT00771394 |
Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00771394 |
Completed |
Astellas Pharma Inc |
2010-01-31 |
| NCT00759135 |
Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate) |
https://ClinicalTrials.gov/show/NCT00759135 |
Completed |
Nymox Corporation |
2008-01-31 |
| NCT00730418 |
Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00730418 |
Completed |
Samsung Medical Center |
2010-03-31 |
| NCT00709488 |
Phase 1 Study of the Litxâ„¢ BPH System in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00709488 |
Completed |
Light Sciences Oncology |
2011-04-30 |
| NCT00706966 |
MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00706966 |
Completed |
University of California, San Francisco |
2008-12-31 |
| NCT00701779 |
Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00701779 |
Completed |
Siami, Paul F., M.D. |
2009-07-31 |
| NCT00700505 |
A Study to Determine the Safety and Efficacy of a New Non-invasive Heating Garment to Reduce Urinary Hesitancy |
https://ClinicalTrials.gov/show/NCT00700505 |
Completed |
ThermaRx, Inc. |
2009-10-31 |
| NCT00680680 |
Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker |
https://ClinicalTrials.gov/show/NCT00680680 |
Completed |
Franklin D. Gaylis, MD Inc. |
2008-02-29 |
| NCT00670306 |
Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00670306 |
Completed |
AEterna Zentaris |
2009-08-31 |
| NCT00663858 |
Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) |
https://ClinicalTrials.gov/show/NCT00663858 |
Completed |
AEterna Zentaris |
2009-09-30 |
| NCT00657839 |
Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00657839 |
Completed |
Bayer |
NA |
| NCT00648323 |
Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement |
https://ClinicalTrials.gov/show/NCT00648323 |
Completed |
Pfizer |
NA |
| NCT00645034 |
A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin |
https://ClinicalTrials.gov/show/NCT00645034 |
Completed |
Pfizer |
NA |
| NCT00637715 |
Once Daily Given Alfuzosin in the Treatment of BPH |
https://ClinicalTrials.gov/show/NCT00637715 |
Completed |
Sanofi |
NA |
| NCT00634608 |
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow |
https://ClinicalTrials.gov/show/NCT00634608 |
Completed |
University of Missouri-Columbia |
2009-03-31 |
| NCT00609596 |
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. |
https://ClinicalTrials.gov/show/NCT00609596 |
Completed |
GlaxoSmithKline |
2008-04-23 |
| NCT01262989 |
SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin |
https://ClinicalTrials.gov/show/NCT01262989 |
Completed |
GlaxoSmithKline |
2010-01-26 |
| NCT00596011 |
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia |
https://ClinicalTrials.gov/show/NCT00596011 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2014-03-25 |
| NCT00547625 |
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems |
https://ClinicalTrials.gov/show/NCT00547625 |
Completed |
Eli Lilly and Company |
NA |
| NCT00540124 |
Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men |
https://ClinicalTrials.gov/show/NCT00540124 |
Completed |
Eli Lilly and Company |
2008-06-30 |
| NCT00537654 |
A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State |
https://ClinicalTrials.gov/show/NCT00537654 |
Completed |
GlaxoSmithKline |
2008-02-22 |
| NCT00527605 |
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00527605 |
Completed |
GlaxoSmithKline |
2009-03-31 |
| NCT00527488 |
Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. |
https://ClinicalTrials.gov/show/NCT00527488 |
Completed |
Ferring Pharmaceuticals |
2009-03-31 |
| NCT00527371 |
PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate |
https://ClinicalTrials.gov/show/NCT00527371 |
Completed |
St. Joseph’s Healthcare Hamilton |
2013-02-28 |
| NCT00517179 |
Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS |
https://ClinicalTrials.gov/show/NCT00517179 |
Completed |
Hospital Authority, Hong Kong |
NA |
| NCT00510406 |
A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH |
https://ClinicalTrials.gov/show/NCT00510406 |
Completed |
Astellas Pharma Inc |
2007-09-30 |
| NCT00475501 |
5-Alpha Reductase and Anabolic Effects of Testosterone |
https://ClinicalTrials.gov/show/NCT00475501 |
Completed |
VA Office of Research and Development |
2012-03-31 |
| NCT00465101 |
A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization |
https://ClinicalTrials.gov/show/NCT00465101 |
Completed |
American Medical Systems |
2012-08-31 |
| NCT00461123 |
Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy |
https://ClinicalTrials.gov/show/NCT00461123 |
Completed |
Bayer |
2008-06-30 |
| NCT00457457 |
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms. |
https://ClinicalTrials.gov/show/NCT00457457 |
Completed |
Pfizer |
2008-04-30 |
| NCT00451191 |
Botulinum Toxin Injection for the Management of BPH |
https://ClinicalTrials.gov/show/NCT00451191 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2009-06-30 |
| NCT00427882 |
Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study |
https://ClinicalTrials.gov/show/NCT00427882 |
Completed |
Handok Inc. |
NA |
| NCT00427219 |
The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate |
https://ClinicalTrials.gov/show/NCT00427219 |
Completed |
Spectrum Pharmaceuticals, Inc |
2008-04-30 |
| NCT00416390 |
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00416390 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00409357 |
Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00409357 |
Completed |
Sanofi |
2005-08-31 |
| NCT00408954 |
Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms |
https://ClinicalTrials.gov/show/NCT00408954 |
Completed |
Pfizer |
2008-06-30 |
| NCT00401661 |
Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin |
https://ClinicalTrials.gov/show/NCT00401661 |
Completed |
Sanofi |
2007-12-31 |
| NCT00399464 |
Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00399464 |
Completed |
Sanofi |
2007-10-31 |
| NCT00386009 |
Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00386009 |
Completed |
Eli Lilly and Company |
2008-05-31 |
| NCT00384930 |
Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00384930 |
Completed |
Eli Lilly and Company |
2007-10-31 |
| NCT00382356 |
Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) |
https://ClinicalTrials.gov/show/NCT00382356 |
Completed |
North Florida/South Georgia Veterans Health System |
2009-07-31 |
| NCT00379067 |
A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. |
https://ClinicalTrials.gov/show/NCT00379067 |
Completed |
Astellas Pharma Inc |
2006-11-30 |
| NCT00375765 |
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer |
https://ClinicalTrials.gov/show/NCT00375765 |
Completed |
GlaxoSmithKline |
2007-07-31 |
| NCT00368979 |
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects |
https://ClinicalTrials.gov/show/NCT00368979 |
Completed |
GlaxoSmithKline |
2007-12-01 |
| NCT00364585 |
A Prospective Evaluation of the GreenLight Model 120 Laser |
https://ClinicalTrials.gov/show/NCT00364585 |
Completed |
Weill Medical College of Cornell University |
NA |
| NCT00359905 |
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH |
https://ClinicalTrials.gov/show/NCT00359905 |
Completed |
Recordati Industria Chimica e Farmaceutica S.p.A. |
2007-05-31 |
| NCT00347061 |
Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPH |
https://ClinicalTrials.gov/show/NCT00347061 |
Completed |
Sanofi |
2007-10-31 |
| NCT00290030 |
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH |
https://ClinicalTrials.gov/show/NCT00290030 |
Completed |
Sanofi |
2004-10-31 |
| NCT00284518 |
Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00284518 |
Completed |
Allergan |
2009-05-31 |
| NCT00280605 |
ALF-ONE : ALFuzosin ONcE Daily |
https://ClinicalTrials.gov/show/NCT00280605 |
Completed |
Sanofi |
2006-02-28 |
| NCT00224133 |
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months |
https://ClinicalTrials.gov/show/NCT00224133 |
Completed |
Watson Pharmaceuticals |
2007-04-30 |
| NCT00224120 |
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo |
https://ClinicalTrials.gov/show/NCT00224120 |
Completed |
Watson Pharmaceuticals |
2006-05-31 |
| NCT00224107 |
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo |
https://ClinicalTrials.gov/show/NCT00224107 |
Completed |
Watson Pharmaceuticals |
2006-08-31 |
| NCT00199550 |
Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) |
https://ClinicalTrials.gov/show/NCT00199550 |
Completed |
Lawson Health Research Institute |
2008-03-31 |
| NCT00194675 |
TRADE-Testosterone Replacement and Dutasteride Effectiveness |
https://ClinicalTrials.gov/show/NCT00194675 |
Completed |
University of Washington |
2010-04-30 |
| NCT00169585 |
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) |
https://ClinicalTrials.gov/show/NCT00169585 |
Completed |
GlaxoSmithKline |
2007-04-30 |
| NCT00143221 |
Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) |
https://ClinicalTrials.gov/show/NCT00143221 |
Completed |
Pfizer |
NA |
| NCT00127179 |
A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140) |
https://ClinicalTrials.gov/show/NCT00127179 |
Completed |
Merck Sharp & Dohme Corp. |
2005-07-01 |
| NCT00111592 |
Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice |
https://ClinicalTrials.gov/show/NCT00111592 |
Completed |
Maastricht University Medical Center |
NA |
| NCT00090103 |
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment |
https://ClinicalTrials.gov/show/NCT00090103 |
Completed |
GlaxoSmithKline |
2009-04-30 |
| NCT00077012 |
Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00077012 |
Completed |
QLT Inc. |
2005-05-31 |
| NCT00062790 |
Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels |
https://ClinicalTrials.gov/show/NCT00062790 |
Completed |
GlaxoSmithKline |
NA |
| NCT00797394 |
Efficacy of Natural Extract 2007RD01 Combined With Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto |
https://ClinicalTrials.gov/show/NCT00797394 |
Completed |
innoVactiv Inc. |
2010-07-31 |
| NCT00037154 |
Saw Palmetto Extract in Benign Prostatic Hyperplasia |
https://ClinicalTrials.gov/show/NCT00037154 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00037141 |
Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) |
https://ClinicalTrials.gov/show/NCT00037141 |
Completed |
American Medical Systems |
NA |
| NCT00029822 |
Clinical Trial in Males With BPH (Enlarged Prostate) |
https://ClinicalTrials.gov/show/NCT00029822 |
Completed |
Sanofi |
NA |
| NCT00486785 |
SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin |
https://ClinicalTrials.gov/show/NCT00486785 |
Completed |
Sanofi |
2007-10-31 |
| NCT00021814 |
Medical Therapy of Prostatic Symptoms |
https://ClinicalTrials.gov/show/NCT00021814 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2001-11-30 |
| NCT00540891 |
The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score |
https://ClinicalTrials.gov/show/NCT00540891 |
Completed |
Sanofi |
NA |